Authors and Disclosures
Martin O'Donnell1–3*, Andrew Mente2,3, Michael H. Alderman4, Adrian J.B. Brady5, Rafael Diaz6, Rajeev Gupta7, Patricio López-Jaramillo8, Friedrich C. Luft9, Thomas F. Lüscher10, Giuseppe Mancia11, Johannes F.E. Mann12, David McCarron13, Martin McKee14, Franz H. Messerli15, Lynn L. Moore16, Jagat Narula17, Suzanne Oparil18, Milton Packer19, Dorairaj Prabhakaran20, Alta Schutte21, Karen Sliwa22, Jan A. Staessen23, Clyde Yancy24 and Salim Yusuf2,3
1HRB-Clinical Research Facility, NUI Galway, Newcastle Road, Galway, Ireland; 2Population Health Research Institute, McMaster University, Hamilton, ON, Canada; 3Hamilton Health Sciences, Hamilton, ON, Canada; 4Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA; 5Department of Cardiology, University of Glasgow, Glasgow, UK; 6Instituto Cardiovascular de Rosario, Estudios Clínicos Latinoamérica, Rosario, Argentina; 7Academic Research Development Unit, Rajasthan University of Health Sciences, Jaipur, Rajasthan, India; 8Fundación Oftalmoló gica de Santander, Instituto Masira, Universidad de Santander, Bucaramanga, Santander, Colombia; 9D Experimental and Clinical Research Center, Max-Delbrück Center for Molecular Medicine, Medical Faculty of the Charité, Berlin, Germany; 10Center for Molecular Cardiology, University of Zurich, Switzerland; 11Department of Medicine and Surgery, University Milano-Bicocca, Milan, Italy; 12KfH Kidney Center, Munich, Germany; 13Private practice, Portland, OR 97209, USA; 14London School of Hygiene and Tropical Medicine, London, UK; 15Department of Cardiology, Inselspital, Bern, Switzerland; 16Preventive Medicine and Epidemiology, Department of Medicine, Boston University School of Medicine, Boston, MA, USA; 17The Mount Sinai Medical Centre, New York, NY, USA; 18Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA; 19Baylor Hear and Vascular Institute, Baylor University Medical Centre, Dallas, TX, USA; 20Centre for Chronic Conditions & Injuries, Public Health Foundation of India, Gurugram, India; 21The George Institute for Global Health, Level 5, 1 King Street, Newtown, New South Wales 2042, Australia; 22Department of Medicine, University of Cape Town, Cape Town, South Africa; 23Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; and 24Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, 676 N Saint Claire, Chicago, IL, USA
*Corresponding author
Tel: +353-91-494098, Email: martin.odonnell@nuigalway.ie
Conflict of interest
All authors have completed the ICMJE uniform disclosure form and declare the following: G.M. reports personal fees from Boehringer-Ingelheim, Ferrer, Medtronic, Menarini, Merck, NOVARTIS, RECORDATI, Servier, outside the submitted work; D.M. reports grants from Academy Nutrition and Dietetics, personal fees from Consultant to Grocery Manufacturers Assoc, ConAgra Foods- Science Advisory Board, outside the submitted work; S.O. reports non-financial support from Global Joint Working Group on Optimal Salt Consumption and Cardiovascular Health, Global Joint Working Group, grants and non-financial support from NIH/National Heart, Lung and Blood Institute (NHLBI), personal fees from Novo Nordisk, Inc, 98point6, Inc, grants and personal fees from George Clinical Pty Ltd/Actelion/Idorsia Pharmaceuticals, personal fees from Cincor Pharma, Inc, Pfizer, Inc, grants and personal fees from ROX Medical, Inc, grants from Bayer, Idorsia Pharmaceuticals, Ltd, Novartis, outside the submitted work; and Writing Group, for the White Paper on Salt and Cardiovascular Disease, World Heart Federation (WHF), European Society of Hypertension (ESH), European Public Health Association (EPH), Writing Group Member, 2015—17 (no fee) and Editor-in-Chief, Current Hypertension Reports (Journal; Publisher—Springer Science Business Media LLC); annual stipend of $5000 (Springer); Editor-in-Chief Term until 12/2020. R.D. reports grants and personal fees from sanofi, grants from PHRI, DCRI, Dalcor, Lepetit, MHICC, Cirius, Amgen, outside the submitted work; D.P. reports grants from Global Alliance for Chronic Disease, outside the submitted work. F.H.M. reports Honoraria and travel from Menarini, Berlin Chemie, Pfizer, and Medtronic. A.E.S. reports personal fees from Abbott Pharmaceuticals, Omron Healthcare, Servier, Novartis South Africa, Takeda Japan, outside the submitted work. All other authors have reported that they have no relationships relevant to the contents of this article to disclose.
